This Article Full Text Full Text (PDF) All Versions of this Article: 144/11/4811    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lassarre, C. Articles by Ricort, J.-M. Search for Related Content PubMed PubMed Citation Articles by Lassarre, C. Articles by Ricort, J.-M.

Growth Factor-Specific Regulation of Insulin Receptor Substrate-1 Expression in MCF-7 Breast Carcinoma Cells: Effects on the Insulin-Like Growth Factor Signaling Pathway

Institut National de la Santé et de la Recherche Médicale (C.L., J.-M.R.), Unité 515, Hôpital Saint-Antoine, 75012 Paris, France; and Centre National de la Recherche Scientifique (J.-M.R.), Unité Mixte de Recherche 8113, Ecole Normale Supérieure de Cachan, 94235 Cachan Cedex, France

Address all correspondence and requests for reprints to: Jean-Marc Ricort, Ecole Normale Supérieure de Cachan, Laboratoire de Biotechnologies et de Pharmacologie Génétique Appliquée, Bâtiment d’Alembert, 61 avenue du Président Wilson, 94235 Cachan Cedex, France. E-mail: ricort{at}lbpa.ens-cachan.fr.

IGFs are potent mitogens that play a crucial role in cell proliferation and/or differentiation and tumorigenesis. Insulin receptor substrate-1 (IRS-1) is a key protein in the IGF signaling pathway in the estrogen-dependent MCF-7 breast carcinoma cell line. In this study, three growth factors [fibroblast growth factor (FGF), epidermal growth factor (EGF), and platelet-derived growth factor (PDGF)] were tested for their ability to modulate IRS-1 protein expression and the IGF-I signaling pathway. FGF and, to a lesser extent, EGF were found to increase IRS-1 protein, whereas PDGF had no effect. This indicates that growth factors can specifically modulate IRS-1 protein content. The increases provoked by EGF and FGF were dependent on the MAPK signaling pathway but independent of phosphatidylinositol 3-kinase (PI 3-kinase) signaling and required de novo protein synthesis. We noted that the kinetics of MAPK activation was continuous in response to FGF but transient in response to EGF. In addition, transfection of cells with a constitutively active form of MAPK kinase, which results in continuous MAPK activity, increased IRS-1 expression. Taken together, these results suggest that stimulation of IRS-1 expression was therefore stronger when MAPK activity was sustained. Pretreatment of cells with EGF, FGF, or PDGF for 24 h reduced IGF-I-induced tyrosine phosphorylation per molecule of IRS-1. However, IGF-I-induced PI 3-kinase activity was decreased by 24 h of pretreatment with EGF or PDGF but not with FGF. Our results therefore demonstrate that different growth factors are capable of specifically modulating the IGF-I signaling via IRS-1. They further suggest that the FGF-induced increase in IRS-1 counterbalances the inhibition of IRS-1 tyrosine phosphorylation to allow normal stimulation of IGF-I-induced PI 3-kinase activity.

This article has been cited by other articles:

				X. Cui, H.-J. Kim, I. Kuiatse, H. Kim, P. H. Brown, and A. V. Lee Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH2-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration. Cancer Res., May 15, 2006; 66(10): 5304 - 5313. [Abstract] [Full Text] [PDF]

				B. Kim, C. M. van Golen, and E. L. Feldman Insulin-Like Growth Factor I Induces Preferential Degradation of Insulin Receptor Substrate-2 through the Phosphatidylinositol 3-Kinase Pathway in Human Neuroblastoma Cells Endocrinology, December 1, 2005; 146(12): 5350 - 5357. [Abstract] [Full Text] [PDF]